Cite
Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis.
MLA
McAllum, Erin J., et al. “Therapeutic Effects of CuII(Atsm) in the SOD1-G37R Mouse Model of Amyotrophic Lateral Sclerosis.” Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, vol. 14, no. 7/8, Dec. 2013, pp. 586–90. EBSCOhost, https://doi.org/10.3109/21678421.2013.824000.
APA
McAllum, E. J., Lim, N. K.-H., Hickey, J. L., Paterson, B. M., Donnelly, P. S., Li, Q.-X., Liddell, J. R., Barnham, K. J., White, A. R., & Crouch, P. J. (2013). Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 14(7/8), 586–590. https://doi.org/10.3109/21678421.2013.824000
Chicago
McAllum, Erin J., Nastasia K.-H. Lim, James L. Hickey, Brett M. Paterson, Paul S. Donnelly, Qiao-Xin Li, Jeffrey R. Liddell, Kevin J. Barnham, Anthony R. White, and Peter J. Crouch. 2013. “Therapeutic Effects of CuII(Atsm) in the SOD1-G37R Mouse Model of Amyotrophic Lateral Sclerosis.” Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration 14 (7/8): 586–90. doi:10.3109/21678421.2013.824000.